Geron and BTX down down down

BioTime was down big, 33 cents to close at $4.53 on 420,000 shares. People are finally seeing that they have no money, and only about $1-2 million coming in and ten times that amount going out. I still like the company's vision and goals, but they will need billions of dollars to make those goals and visions come true. I will buy a little more under $4.........Geron down 14 cents at $1.49 on 1 million shares. They have more money then BTX but only one possible product that will need 2 more years of trials. Happy I sold most of my shares. .....ACTC up at 8 cents, they need money, results and a partner soon, may buy more under 7 cents for a quick trade..... AAPL at $456.91, all I can say is the market is crazy, Amazon missed earnings and it went up. AAPL missed just a little and down it went, it's PE is around 10 and Amazon is over 80 un-real....Good luck in this rigged casino,

AAPL dives

I'm so gald I only have a few shares of AAPL, down $63.51 on very heavy volume of 52.2 million shares, so I only lost 2Gs on paper. .......Geron was down 1 cent to close at $1.64 on light volume of 645,171 shares, no news.....ACTC down under 8 cents at 0.0781, no news. BTX unchanged at $4.76 on avg. volume, no news. ...Good luck in this rigged casino.

BTX up again

BioTime was up 3 cents at $4.76, on good volume of 430,358 shares the three month avg. is 194,992 shares. I went to there website to hear the Lastest Information I clicked it on. It was on ECI Scale-up and Manufacturing of Cell Based Therapies II. I didn't understand it at all. Went and click the latest video, Product Development Update: Life Map Discovery, much better, I like what they are doing. But I wish I knew were the money is going to come from to run the trials. I will buy a few more shares, not many, been burned too many times............................................. AAPL earnings missed, all hope is gone, will washout at around $325 then if they can come up with new products that we all have to have, it will do a slow climb to $450, maybe. ...............Good luck in this rigged casino

BioTime back up

BioTime closed up 12 cents on very good volume of 459,511 shares, the three month avg. is 181,492 shares. Something is up with them, it may be good and it may be bad. The volume and price action say good for know. After losing more money then I care to think about over the 30 years of gambling and it is a gamble it could be bad....Good luck in this rigged casino,

Patients with Better Vision to be Enrolled in ACTC

Patients with Better Vision to be Enrolled in ACT's Clinical Trials for Macular Degeneration Jan 22, 2013 08:30:02 (ET) MARLBOROUGH, Mass., Jan 22, 2013 (BUSINESS WIRE) -- Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTC or the "Company"), a leader in the field of regenerative medicine, announced today that it is amending the patient treatment protocol for the remainder of the Company's Phase I clinical trials for Stargardt's macular dystrophy (SMD) and dry age-related macular degeneration (dry AMD) currently being conducted in the U.S. and will also submit an amendment in Europe for the SMD trial being conducted there. Patients with better vision, a visual acuity of 20/100, will be eligible for enrollment in the remainder of the trials. By treating patients earlier in the course of the disease, the Company believes that the amended patient protocol will have a more significant impact on photoreceptor rescue and visual function. In previous protocols, only SMD patients with a visual acuity no better than hand movement in the treated eyes and dry AMD patients with a visual acuity of 20/400 were eligible. "Having recently reached the halfway point in our three clinical trials for macular degeneration, now is an opportune time to pursue modifications which could help accelerate the pace of all three trials," said Gary Rabin, chairman and CEO. "The advanced age of many of our enrolled patients has tended to limit the pace at which we are able to enroll and treat them, since other, unrelated health complications tend to come up more frequently in the elderly. Patients with better vision tend to be younger on average." The Company plans to institute the amended patient protocols upon receipt of Institutional Review Board (IRB) approval from each of the clinical sites, for the second half of all the clinical trials. "We are pleased to be able to expand patient enrollment in all three of our ongoing clinical trials," said Robert Lanza, M.D., ACT's chief scientific officer. "Not only does it have the potential to accelerate the road to the completion of Phase I, but having a more diverse patient population could also provide additional clinical insights." Good news stock was up a little. Good luck in this rigged casino.

BTX down 3rd day

BioTime is down again 8 cents at $4.61, on 494,198 shares. The three month avg. volume is 173,844. ....................ACTC had a good day, Thursday they stated there last law suit was settled for 12.5 million dollars, most of it will be in stock. They have $8 million in the bank. You would think the share price would go down. BUT NO it went up and closed at 0.0881 on 21.5 million shares. The three month avg. is 8.7 million shares. .................Good luck in this rigged casino.

BTX down again 2nd day

Well all good things must come to an end. BTX closed down 19 cents at $4.69 on 465,140 shares. The 3 month avg. volume is 166,466 shares. I think this was a pump and dump. The big boys run the stock up, buy calls, selling them before they dump and buying puts before they dump. Then sell the puts way they drive the price down by dumping the shares. Making alot of money on the way up and on the way down...........Good luck in this rigged casino,